ERCP topics

Introduction

Endoscopic retrograde cholangiopancreatography (ERCP) has evolved significantly during the last two decades. While endoscopic management of biliary obstruction was initially hailed as a breakthrough, ERCP has developed tremendously and now offers a number of therapeutic applications. Although many endoscopists have expanded their armamentarium to include complex and controversial areas such as the management of pancreatitis, fluid collections, and sphincter of Oddi dysfunction (SOD), serious complications continue to occur. Numerous abstracts presented at this year’s Digestive Disease Week (DDW) meeting addressed new techniques, while others focused on improving procedure safety. Selected abstracts are reviewed here.

References

• 1 Cheon Y K, Fogel E L, McHenry L. et al . Frequency and severity of post-ERCP pancreatitis correlated with extent of pancreatic ductal opacification [abstract].  Gastrointest Endosc. 2006;  63 AB87
• 2 Varadarajulu S, Wilcox C M. Prospective randomized trial comparing needle-knife and pull-papillotome techniques for pancreatic sphincterotomy in high-risk patients [abstract].  Gastrointest Endosc. 2006;  63 AB85
• 3 Bailey A A, Lynch P M, Lee E Y. et al . Results of a randomized trial of cannulation technique in ERCP: effects on technical success and post ERCP pancreatitis [abstract].  Gastrointest Endosc. 2006;  63 AB284
• 4 Yoo K S, Shin W G, Jung J O. et al . Oral camostat for prevention of post-ERCP pancreatitis: a pilot study [abstract].  Gastrointest Endosc. 2006;  63 AB307
• 5 Kapetanos D, Kokozidis G, Christodoulou D. et al . A randomized controlled study of pentoxifylline on the prevention of post-ERCP pancreatitis [abstract].  Gastrointest Endosc. 2006;  63 AB308
• 6 Benvenuti S, Zancanella L, Piazzi L. et al . Prevention of post-ERCP pancreatitis with somatostatin versus gabexate mesylate: a randomized placebo controlled multicenter study [abstract].  Gastrointest Endosc. 2006;  63 AB309
• 7 Beauchant M, Barrioz T. Intravenous nitroglycerin for the prevention of pancreatitis after therapeutic endoscopic retrograde cholangiography (ERC): a randomized, double blind, placebo controlled multicenter trial [abstract].  Gastrointest Endosc. 2006;  63 AB303
• 8 Fogel E L, Alazmi W, Schmidt S. et al . Clinical utility of pre-operative hemostatic screening tests (PHSTs) in patients undergoing outpatient ERCP [abstract].  Gastrointest Endosc. 2006;  63 AB300
• 9 Meisner S, Pleskow D K, Chen Y K. Pilot evaluation of a direct visualization probe for intraductal examination of the biliary system [abstract].  Gastrointest Endosc. 2006;  63 AB87
• 10 Chen Y K. Results from the first human use clinical series utilizing a new peroral cholangiopancreatoscopy system (Spyglass^TM Direct Visualization System) [abstract].  Gastrointest Endosc. 2006;  63 AB88
• 11 Hoffman A W, Kiesslich R, Lammersdorf K. et al . Methylene blue cholangioscopy for the detection of neoplastic biliary lesions [abstract].  Gastrointest Endosc. 2006;  63 AB288
• 12 Tischendorf J JW, Meier P N, Schneider A. et al . Transpapillary intraductal ultrasound (IDUS) in the evaluation of dominant bile duct stenoses in patients with primary sclerosing cholangitis [abstract].  Gastrointest Endosc. 2006;  63 AB302
• 13 Levy M J, Rumalla A, Baron T H. et al . Prospective evaluation of intraductal ultrasound (IDUS), digital image analysis (DIA), fluorescence in situ hybridization (FISH), CA 19 - 9, and ERCP with routine cytology and intraductal biopsy in the evaluation of indeterminate bile duct strictures [abstract].  Gastrointest Endosc. 2006;  63 AB88
• 14 Sanders M K, Howell D, Bernadino K P. et al . Expanded tissue sampling protocol incorporating a new forceps biopsy technique at ERCP maximizes diagnostic sensitivity [abstract].  Gastrointest Endosc. 2006;  63 AB281
• 15 Weinberg B, Shindy W, Simon L K. Endoscopic balloon dilation (sphincteroplasty) vs sphincterotomy for common bile duct stones: a Cochrane collaboration meta-analysis [abstract].  Gastrointest Endosc. 2006;  63 AB291
• 16 Tsujino T, Sasaki T, Togawa O. et al . Outcome in 1,000 patients with bile duct stones treated with endoscopic papillary balloon dilation [abstract].  Gastrointest Endosc. 2006;  63 AB297
• 17 Carnes M, Cotton P B, Hawes R H. et al . Combined endoscopic biliary sphincterotomy and large balloon dilation for large common bile duct stones [abstract].  Gastrointest Endosc. 2006;  63 AB287
• 18 Evans W B, Draganov P, Forsmark C. Large size balloon dilation of the ampulla after biliary sphincterotomy can facilitate endoscopic extraction of complicated bile duct stones [abstract].  Gastrointest Endosc. 2006;  63 AB283
• 19 Lee S J, Hwang S J, Lee D K. et al . Simultaneous endoscopic papillary balloon dilatation and EST for easy removal of large and multiple CBD stones [abstract].  Gastrointest Endosc. 2006;  63 AB281
• 20 Kim D K, Kwon H Y, Choi J H. et al . Endoscopic large balloon sphincteroplasty along with endoscopic sphincterotomy (ELBS-EST) in patients with large extrahepatic bile duct stones [abstract].  Gastrointest Endosc. 2006;  63 AB283
• 21 Minami A, Nomoto T, Moriyama T. Small sphincterotomy combined with papillary dilation with large balloon permits retrieval of large stones without crushing.  Gastrointest Endosc. 2006;  63 AB303
• 22 Tanaka S, Mitsui K, Tatsuguchi A. et al . Usefulness of double-balloon endoscopy for diagnosis and treatment of the post-operative gastrointestinal tract [abstract].  Gastrointest Endosc. 2006;  63 AB291
• 23 Kinney T P, Malley S, Hunter D, Lai R, Freeman M L. Pancreatic therapeutic ERCP following Whipple resection: rendezvous is the rule [abstract].  Gastrointest Endosc. 2006;  63 AB291
• 24 Pleskow D, Ornellas L, Stefanidis G. et al . Covered Wallstent for palliation of malignant biliary obstruction: retrospective single center study of 103 patients [abstract].  Gastrointest Endosc. 2006;  63 AB308
• 25 Kawamoto H, Kato H, Hirao K. et al . The metallic stent for the patients with malignant biliary stenosis induced by advanced pancreatic cancer: covered stent or uncovered stent in chemotherapy cases? [abstract].  Gastrointest Endosc. 2006;  63 AB305
• 26 Moses P L, Alan B N, Gordon S R. et al . A randomized multicenter trial comparing plastic to covered metal stents for the palliation of lower malignant biliary obstruction [abstract].  Gastrointest Endosc. 2006;  63 AB289
• 27 Toouli J, Geenen J, Kawamoto M. et al . Sleeve sphincter of Oddi (SO) manometry: accurate and safe [abstract].  Gastrointest Endosc. 2006;  63 AB292
• 28 Varadarajulu S, Wilcox C M. Prospective evaluation of ketamine on sphincter of Oddi motility [abstract].  Gastrointest Endosc. 2006;  63 AB281
• 29 Freeman M, Finke M, Allen J, Johnson E. Gastric pacemaker for gastroparesis in patients with refractory symptoms after endoscopic therapy for sphincter of Oddi dysfunction or pancreas divisum [abstract].  Gastrointest Endosc. 2006;  63 AB86
• 30 Arvanitakis M, Delhaye M, Bali M A. et al . Pancreatic fluid collection: a prospective randomized controlled trial regarding stent removal following endoscopic transmural drainage [abstract].  Gastrointest Endosc. 2006;  63 AB309
• 31 Laukkarinen J M, Lamsa T, Nordback L. et al . A novel biodegradable pancreatic stent for human pancreatic applications: a preclinical study in a large animal model [abstract].  Gastrointest Endosc. 2006;  63 AB85
• 32 Kahaleh M, McDonough P, Rockoff T. et al . Factors predictive of resolution in pancreatic duct disruptions treated endoscopically: a 10 year single-center experience [abstract].  Gastrointest Endosc. 2006;  63 AB86
• 33 Kamisawa T, Egawa N, Nakajima H. et al . The usefulness of biopsying the major duodenal papilla to diagnose autoimmune pancreatitis: a prospective study using IgG4-immunostaining [abstract].  Gastrointest Endosc. 2006;  63 AB86
• 34 Kubota K, Fujisawa T, Inamori M. et al . Clinical impact of the swollen duodenal papilla in autoimmune pancreatitis [abstract].  Gastrointest Endosc. 2006;  63 AB309